ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,803
Screening encounters
3,145
Diagnostic referrals
616
Outstanding pathways
250

Screening pathway

  1. Screening3,145Encounters
  2. Positive finding1,076Documented findings
  3. Referral616Diagnostic referrals
  4. Follow-up705Diagnostic visits
  5. Outcome366Resolved pathways

Stage totals use different units. Pending pathways: 250. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0484 · EXP-0484Synthetic · Site A

Full participant history through 2026-05-16, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2025-09-21
  4. · Diagnostic referral · EXP-0484-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Diagnostic visit · Missed

Referral-time risk

Pathway status at observation · Pending

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

2803 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0499 · Expanded synthetic participant 0499Site A — Urban Referral Hub
EXP-0500 · Expanded synthetic participant 0500Site A — Urban Referral Hub
EXP-0501 · Expanded synthetic participant 0501Site A — Urban Referral Hub
EXP-0502 · Expanded synthetic participant 0502Site D — Community Engagement Programme
EXP-0503 · Expanded synthetic participant 0503Site C — Rural Outreach Programme
EXP-0508 · Expanded synthetic participant 0508Site B — Peri-Urban Access Programme
EXP-0509 · Expanded synthetic participant 0509Site B — Peri-Urban Access Programme
EXP-0510 · Expanded synthetic participant 0510Site D — Community Engagement Programme
EXP-0511 · Expanded synthetic participant 0511Site D — Community Engagement Programme
EXP-0518 · Expanded synthetic participant 0518Site A — Urban Referral Hub
EXP-0524 · Expanded synthetic participant 0524Site A — Urban Referral Hub
EXP-0528 · Expanded synthetic participant 0528Site D — Community Engagement Programme
EXP-0529 · Expanded synthetic participant 0529Site C — Rural Outreach Programme
EXP-0531 · Expanded synthetic participant 0531Site D — Community Engagement Programme
EXP-0532 · Expanded synthetic participant 0532Site D — Community Engagement Programme
EXP-0534 · Expanded synthetic participant 0534Site B — Peri-Urban Access Programme
EXP-0536 · Expanded synthetic participant 0536Site D — Community Engagement Programme
EXP-0537 · Expanded synthetic participant 0537Site B — Peri-Urban Access Programme
EXP-0538 · Expanded synthetic participant 0538Site A — Urban Referral Hub
EXP-0540 · Expanded synthetic participant 0540Site E — Resource-Constrained Navigation Programme
EXP-0545 · Expanded synthetic participant 0545Site E — Resource-Constrained Navigation Programme
EXP-0547 · Expanded synthetic participant 0547Site A — Urban Referral Hub
EXP-0548 · Expanded synthetic participant 0548Site A — Urban Referral Hub
EXP-0550 · Expanded synthetic participant 0550Site E — Resource-Constrained Navigation Programme
EXP-0551 · Expanded synthetic participant 0551Site A — Urban Referral Hub

Programme insights

Encounters by modality

VIA
1281
HPV DNA
1401
Cytology
463

Navigation activity

Barrier documented
529
Contact attempt
906
Navigation intervention
224
Diagnostic booking
758
Diagnostic visit
705

Documented barriers

Contact difficulty
175
Transport difficulty
163
Appointment coordination
191

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.